133 related articles for article (PubMed ID: 16757679)
1. Topical alprostadil treatment of female sexual arousal disorder.
Kielbasa LA; Daniel KL
Ann Pharmacother; 2006; 40(7-8):1369-76. PubMed ID: 16757679
[TBL] [Abstract][Full Text] [Related]
2. Topical alprostadil in the treatment of Female Sexual Arousal Disorder: a pilot study.
Islam A; Mitchel J; Rosen R; Phillips N; Ayers C; Ferguson D; Yeager J
J Sex Marital Ther; 2001; 27(5):531-40. PubMed ID: 11554216
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of topical alprostadil cream for the treatment of female sexual arousal disorder (FSAD): a double-blind, multicenter, randomized, and placebo-controlled clinical trial.
Padma-Nathan H; Brown C; Fendl J; Salem S; Yeager J; Harningr R
J Sex Marital Ther; 2003; 29(5):329-44. PubMed ID: 14504005
[TBL] [Abstract][Full Text] [Related]
4. Topical alprostadil (PGE1) for the treatment of female sexual arousal disorder: in-clinic evaluation of safety and efficacy.
Heiman JR; Gittelman M; Costabile R; Guay A; Friedman A; Heard-Davison A; Peterson C; Dietrich J; Stephens D
J Psychosom Obstet Gynaecol; 2006 Mar; 27(1):31-41. PubMed ID: 16752874
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of alprostadil cream for the treatment of female sexual arousal disorder: a double-blind, placebo-controlled study in chinese population.
Liao Q; Zhang M; Geng L; Wang X; Song X; Xia P; Lu T; Lu M; Liu V
J Sex Med; 2008 Aug; 5(8):1923-31. PubMed ID: 18564348
[TBL] [Abstract][Full Text] [Related]
6. Randomized, placebo-controlled, double blind, crossover design trial of the efficacy and safety of Zestra for Women in women with and without female sexual arousal disorder.
Ferguson DM; Steidle CP; Singh GS; Alexander JS; Weihmiller MK; Crosby MG
J Sex Marital Ther; 2003; 29 Suppl 1():33-44. PubMed ID: 12735087
[TBL] [Abstract][Full Text] [Related]
7. Duplex Doppler ultrasound assessment of clitoral hemodynamics after topical administration of alprostadil in women with arousal and orgasmic disorders.
Bechara A; Bertolino MV; Casabé A; Munarriz R; Goldstein I; Morin A; Secin F; Literat B; Pesaresi M; Fredotovich N
J Sex Marital Ther; 2003; 29 Suppl 1():1-10. PubMed ID: 12735085
[TBL] [Abstract][Full Text] [Related]
8. Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction.
Brown DA; Kyle JA; Ferrill MJ
Ann Pharmacother; 2009 Jul; 43(7):1275-85. PubMed ID: 19509350
[TBL] [Abstract][Full Text] [Related]
9. Treatment options for female sexual arousal disorder: part II.
Feldhaus-Dahir M
Urol Nurs; 2010; 30(4):247-51. PubMed ID: 20949811
[TBL] [Abstract][Full Text] [Related]
10. [Multicenter randomized, double-blind, placebo-controlled trial of prostaglandin E1 cream for female sexual arousal disorder].
Zhang M; Liao QP; Yao C; Geng L; Wang XP; Song XH; Zhao J; Lv T; Lv MQ; Chen L; Yao YJ; Xia B; Zhang HZ; Wang QX; Lu JL
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 42(6):727-33. PubMed ID: 21170106
[TBL] [Abstract][Full Text] [Related]
11. Clitoral hemodynamic changes after a topical application of alprostadil.
Becher EF; Bechara A; Casabe A
J Sex Marital Ther; 2001; 27(5):405-10. PubMed ID: 11554200
[TBL] [Abstract][Full Text] [Related]
12. Transdermal and topical pharmacotherapy for male sexual dysfunction.
Ohebshalom M; Mulhall JP
Expert Opin Drug Deliv; 2005 Jan; 2(1):115-20. PubMed ID: 16296739
[TBL] [Abstract][Full Text] [Related]
13. Long-term, multicenter study of the safety and efficacy of topical alprostadil cream in male patients with erectile dysfunction.
Rooney M; Pfister W; Mahoney M; Nelson M; Yeager J; Steidle C
J Sex Med; 2009 Feb; 6(2):520-34. PubMed ID: 19138370
[TBL] [Abstract][Full Text] [Related]
14. An integrated analysis of alprostadil topical cream for the treatment of erectile dysfunction in 1732 patients.
Padma-Nathan H; Yeager JL
Urology; 2006 Aug; 68(2):386-91. PubMed ID: 16904458
[TBL] [Abstract][Full Text] [Related]
15. Oral phentolamine and female sexual arousal disorder: a pilot study.
Rosen RC; Phillips NA; Gendrano NC; Ferguson DM
J Sex Marital Ther; 1999; 25(2):137-44. PubMed ID: 10327383
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological treatment of sexual dysfunction in women].
Hilmand CB; Gregersen N; Giraldi AG
Ugeskr Laeger; 2002 Oct; 164(41):4794-6. PubMed ID: 12407886
[No Abstract] [Full Text] [Related]
17. Effects of experimentally adopted sexual schemas on vaginal response and subjective sexual arousal: a comparison between women with sexual arousal disorder and sexually healthy women.
Middleton LS; Kuffel SW; Heiman JR
Arch Sex Behav; 2008 Dec; 37(6):950-61. PubMed ID: 18256919
[TBL] [Abstract][Full Text] [Related]
18. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
19. Drug treatment of paraphilic and nonparaphilic sexual disorders.
Guay DR
Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704
[TBL] [Abstract][Full Text] [Related]
20. Drugs in early clinical development for the treatment of female sexual dysfunction.
Belkin ZR; Krapf JM; Goldstein AT
Expert Opin Investig Drugs; 2015 Feb; 24(2):159-67. PubMed ID: 25376023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
